Диссертация (1174310), страница 21
Текст из файла (страница 21)
– Vol. 152. – P. 978 – 979.149. Copper in Drinking Water [Electronic resource] / National Research Council (US)Committee on Copper in Drinking Water. – Washington (DC): National Academies127Press(US),2000.–147p.–Modeofaccess:https://www.nap.edu/read/9782/chapter/1.150. Nayak, N. C., Chitale, A. R. Indian childhood cirrhosis (ICC) & ICC–like diseases:The changing scenario of facts versus notions / N. C.
Nayak, A. R. Chitale // TheIndian Journal of Medical Research. – 2013. – Vol. 137(6). – P. 1029–1042.151. Wilson’s disease presenting in a family with an apparent dominant history of tremor/ D. Nicholl, P. Ferenci, C. Polli, M. Burdon, H. Pall // Journal of Neurology,Neurosurgery, and Psychiatry.
– 2001. – Vol. 70(4). – P. 514–516.152. Diagnostic challenges of Wilson’s disease presenting as acute pancreatitis,cholangitis, and jaundice / E. Nussinson, A. Shahbari, F. Shibli, E. Chervinsky, P.Trougouboff, A. Markel // World Journal of Hepatology. – 2013.
– Vol. 5(11). – P.649–653.153. Wilson's disease in Ireland: increasing prevalence over 40 years / M. O'Brien, K.Kinsella, M. Reilly [et al.] // J Neurol Neurosurg Psychiatry. – 2012. – Vol. 83. – P.A13.154. Mutational analysis of ATP7B and genotype–phenotype correlation in Japanese withWilson's disease / T. Okada, Y. Shiono, H. Hayashi, H. Satoh, T.
Sawada, A. Suzuki,Y. Takeda, M. Yano, K. Michitaka, M. Onji, H. Mabuchi // Hum Mutat. – 2000. –Vol. 15(5). – P. 454–462.155. Estimate of the frequency of Wilson's disease in the US Caucasian population: amutation analysis approach / L. Olivarez, M. Caggana, K.A. Pass, P. Ferguson, G.J.Brewer // Ann Hum Genet. – 2001. – Vol. 65. – P. 459–463.156. Estimation of Allele Frequencies and Population Incidence of Wilson Disease inBrazil / P.A. Otto, M.M. Deguti, T.F. Araújo, E.R. Barbosa, R.S.D. Bem [et al.] //Prensa Med Argent. – 2016. – Vol.
102. – P. 5.157. Parekh, J. R., Agrawal, P. R. Wilson’s disease: “face of giant panda” and “trident”signs together / J. R. Parekh, P. R. Agrawal // Oxford Medical Case Reports. – 2014.– Vol. 1. – P. 16–17.128158. Wilson’s disease in Scotland / R. H. Park, P. McCabe, G. S. Fell, R.
I. Russell // Gut.– 1991. – Vol. 32(12). – Vol. 1541–1545.159. Biometals in rare neurodegenerative disorders of childhoodn / S. J. Parker, J.Koistinaho, A. R. White, K. M. Kanninen // Frontiers in Aging Neuroscience. –2013. – Vol. 5. – P. 14.160. Pena, M.M.O., Lee, J. Thiele, D.J. A Delicate Balance: Homeostatic Control ofCopper Uptake and Distribution / M.M.O. Pena, J. Lee, D.J. Thiele // J. Nutr. – 1999.– Vol. 129(7). – P. 1251–1260.161.
Wilson disease—keeping the bar for diagnosis raised / R.E. Perri, S.H. Hahn, M.J.Ferber, P.S. Kamath // Hepatology. – 2005. – Vol. 42(4). – P. 974.162. Pfeiffer, R.F. Wilson’s Disease / R.F. Pfeiffer // Semin Neurol. – 2007. – Vol. 27(2).– P. 123–132.163. Phillips, M.C. Apolipoprotein E isoforms and lipoprotein metabolism / M.C.
Phillips// IUBMB Life. – 2014. – Vol. 66(9). – P. 616–623.164. Poon, K.S., Tan, K.M. Targeted next–generation sequencing of the ATP7B gene formolecular diagnosis of Wilson disease / K.S. Poon, K.M. Tan, E.S. Koay // ClinicalBiochemistry. – 2016. – Vol. 49(1–2). – P. 166–171.165. Unique genetic profile of hereditary hemochromatosis in Russians: high frequencyof C282Y mutation in population, but not in patients / E.S.
Potekhina, A.V. Lavrov,L.M. Samokhodskaya, A.Y. Efimenko [et al.] // Blood Cells Mol Dis. – 2005. – Vol.35(2). – P. 182–188.166. Characteristics and prevalence of Wilson’s disease: A 2013 observationalpopulation–based study in France / A. Poujois, F. Woimant, S. Samson [et al.] //Clin Res Hepatol Gastroenterol. – 2017. – Vol. 42(1). – P. 57–63.167. Haemolytic onset of Wilson disease in a patient with homozygous truncation ofATP7B at Arg1319 / M.
Prella, R. Baccalà, J.D. Horisberger [et al.] // Br J Haematol.– 2001. – Vol. 114(1). – P. 230–232.129168. Rahul, K., Anandh, K., Sonal, G. Wilson's disease masquerading as rheumatoidarthritis / K. Rahul, K.Anandh, G. Sonal // Indian Journal of Medical Specialities. –2015. – Vol. 6. – Issue 1. – P. 33–35.169. Wilson's disease in India: clinical and laboratory manifestations in thirty patients /K. Raiamani, R.N. Sharma, G. John, J.M. Raju [et al.] // J Assoc Physicians India.
–1987. – Vol35(6). – P. 438–441.170. An Early Sign of Wilson’s Disease: Dysarthria / J.L. Ratan, C. Urmi, G. Surender,P. Biplab, L. Mangala // Journal of Clinical and Diagnostic Research. – 2014. – Vol.8(3). – P. 188.171. Roberts, E.A. Using metalloproteomics to investigate the cellular physiology ofcopper in hepatocytes / E.A. Roberts // Metallomics. – 2012. – Vol. 4(7). – P. 633–640.172. Roberts, E.A., Robinson, B.H. Mitochondrial structure and function in the untreatedJackson toxic milk (tx–j) mouse, a model for Wilson disease / E.A.
Roberts, B.H.Robinson, S. Yang // Mol Genet Metab. – 2008. – Vol. 93. – P. 54–65.173. Roberts, E. A., Schilsky, M. L. Diagnosis and treatment of Wilson disease: Anupdate / E. A. Roberts, M. L. Schilsky // Hepatology. – 2008. – Vol. 47. – P. 2089–2111.174. Dietary copper restriction in Wilson's disease / K. Russell, L.K.
Gillanders, D.W.Orr, L.D. Plank // Eur J Clin Nutr. – 2018. – Vol. 72(3). – P. 326–331.175. ATP7B mutations in families in a predominantly Southern Indian cohort of Wilson'sdisease patients / S. Santhosh, R.V. Shaji, C.E. Eapen [et al.] // Indian JGastroenterol. – 2006. – Vol. 25(6). – P.
277–282.176. Variations in genotype–phenotype correlations in phenylketonuria patients / L.L.Santos, C.G. Fonseca, A.L. Starling [et al.] // Genet Mol Res. – 2010. – Vol. 9(1). –P. 1–8.177. Scheiber, I.F., Brůha, R. Pathogenesis of Wilson disease / I.F. Scheiber, R. Brůha,P. Dušek // Handb Clin Neurol. – 2017. – Vol.
142. – P. 43–55.130178. The impact of apolipoprotein E genotypes on age at onset of symptoms andphenotypic expression in Wilson's disease / M. Schiefermeier, H. Kollegger, C.Madl [et al.] // Brain. – 2000. – Vol. 123. – P. 585–590.179. Seo, J. K. Diagnosis of Wilson Disease in Young Children: Molecular GeneticTesting and a Paradigm Shift from the Laboratory Diagnosis / J. K.
Seo // PediatricGastroenterology, Hepatology & Nutrition. – 2012. – Vol. 15(4). – P. 197–209.180. Identification and analysis of mutations in the Wilson disease gene (ATP7B):population frequencies, genotype–phenotype correlation, and functional analyses /A. B. Shah, I. Chernov, H. T. Zhang [et al.] // American Journal of Human Genetics.– 1997. – Vol.
61(2). – P. 317–328.181. Wilson's disease in children and adolescents: diagnosis and treatment / S.A. Sócio,A.R. Ferreira, E.D.T. Fagundes [et al.] // Revista Paulista de Pediatria. – 2010. –Vol. 28(2). – P. 134–140.182. The H1069Q mutation in ATP7B is associated with late and neurologic presentationin Wilson disease: results of a meta–analysis / J.M. Stapelbroek, C.W. Bollen, J.K.van Amstel [et al.] // J Hepatol. – 2004. – Vol. 41.
– P. 758–763.183. Wilson´s disease in patients presenting with liver disease: a diagnostic challenge /P. Steindl, P. Ferenci, H.P. Dienes [et al.] // Gastroenterology. – 1997. – Vol. 113. –P. 212–218.184. Sternlieb, I. Wilson's disease / I. Sternlieb // Clin Liver Dis.
– 2000. – Vol. 4(1). –P. 229–239.185. Analysis of the human homologue of the canine copper toxicosis gene MURR1 inWilson disease patients / B. Stuehler, J. Reichert, W. Stremmel, M. Schaefer // J MolMed. – 2004. – Vol. 82(9). – P. 629–634.186. Wilson’s disease – A rare cause of renal tubular acidosis with metabolic bone disease/ D.K.S. Subrahmanyam, M. Vadivelan, S. Giridharan, N.
Balamurugan // IndianJournal of Nephrology. – 2014. – Vol. 24(3). – P. 171–174.131187. Tapiero, H., Townsend, D.M. Trace elements in human physiology and pathology /H. Tapiero, D.M. Townsend, K.D. Tew // Copper. Biomed Pharmacother. – 2003. –Vol. 57(9). – P. 386–398.188.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
